Shandong Suncadia Medicine Co., Ltd.

This study tested whether two different oral medications could help people with chronic kidney disease. Researchers enrolled 181 adults who were already on standard blood pressure medications. They measured how well the drugs reduced protein in urine and protected kidney function…

This study tested whether a new oral medication called HRS-5346 could safely lower levels of lipoprotein(a), a fatty particle in the blood linked to heart attack and stroke risk. It involved 120 adults who already had heart disease or were at high risk for it and had high lipopro…

This study tested whether the investigational drug HRS-7535 can help protect the kidneys in adults with type 2 diabetes who have early to moderate diabetic kidney disease. For 16 weeks, 281 participants received either HRS-7535 or a placebo (inactive pill) to see if the drug safe…

This study followed 81 people with obesity to check the long-term safety and continued weight loss effects of an experimental drug called HRS-7535. It was an extension of a previous trial, so all participants had already taken the drug for 36 weeks. Researchers tracked side effec…

This study tested whether a new oral medication called HRS-7535 could help adults with type 2 diabetes who still had high blood sugar despite taking two common diabetes drugs (metformin and an SGLT2 inhibitor). For 16 weeks, 155 participants received either the new drug or a plac…

This early-stage study aimed to check the safety and basic effects of a new pain medication called HRS-2129. It involved 23 healthy adults who received the drug and underwent tests to see how it changed their sensitivity to hot and cold pain. The main goal was to see if the drug …

This early study tested how a common antifungal drug (itraconazole) affects the way the body processes a new experimental breast cancer drug (HRS-8080). Researchers gave both drugs to 16 healthy volunteers to measure drug levels in the blood and check for safety. The goal was to …

This study examined how HRS-1893, an experimental medication for hypertrophic cardiomyopathy, behaves in people with reduced kidney function compared to healthy people. Researchers measured drug levels in the blood of 24 participants to understand how kidney impairment affects th…

This was a small, early-stage study to see how a new drug called HRS-1301 affects the way the body processes a common cholesterol-lowering medicine (rosuvastatin). It involved 16 healthy adults to measure drug levels in the blood and check for safety. The main goal was to gather …

This was an early-stage study to check the safety of a new experimental drug called HRS-1301, which is being developed to treat high cholesterol. It involved 82 healthy volunteers who received either the drug or a placebo. The main goal was to see how well people tolerated the dr…

This study looked at how a potential new diabetes medication, HRS-7535, is processed by the body and how safe it is in people with mild to moderate liver problems compared to people with normal liver function. It involved 24 adults to measure the drug's levels in the blood and ch…